Open-Label Pilot Study to Compare the Safety and Immunogenicity of Pentavalent Rotavirus Vaccine (RV5) Administered on an Early Alternative Dosing Schedule with Those of RV5 Administered on the Recommended Standard Schedule.
Publication
, Journal Article
Saleh, E; Eichner, B; Clark, DW; Gagliano, ME; Troutman, JM; Harrington, L; McNeal, M; Clements, D
Published in: J Pediatric Infect Dis Soc
February 19, 2018
This study compares the safety and immunogenicity of pentavalent rotavirus vaccine (RV5) administered on an alternative schedule (initiated at 2-5 weeks of age) with those of RV5 administered on the recommended standard schedule. Our findings support the future conduct of larger clinical trials to confirm the safety and efficacy of rotavirus vaccination in the neonatal period.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Pediatric Infect Dis Soc
DOI
EISSN
2048-7207
Publication Date
February 19, 2018
Volume
7
Issue
1
Start / End Page
82 / 85
Location
England
Related Subject Headings
- Vaccines, Attenuated
- Rotavirus Vaccines
- Rotavirus Infections
- Rotavirus
- Pilot Projects
- Male
- Infant, Newborn
- Infant
- Immunization Schedule
- Humans
Citation
APA
Chicago
ICMJE
MLA
NLM
Saleh, E., Eichner, B., Clark, D. W., Gagliano, M. E., Troutman, J. M., Harrington, L., … Clements, D. (2018). Open-Label Pilot Study to Compare the Safety and Immunogenicity of Pentavalent Rotavirus Vaccine (RV5) Administered on an Early Alternative Dosing Schedule with Those of RV5 Administered on the Recommended Standard Schedule. J Pediatric Infect Dis Soc, 7(1), 82–85. https://doi.org/10.1093/jpids/pix005
Saleh, Ezzeldin, Brian Eichner, Douglas W. Clark, Martha E. Gagliano, James M. Troutman, Lynn Harrington, Monica McNeal, and Dennis Clements. “Open-Label Pilot Study to Compare the Safety and Immunogenicity of Pentavalent Rotavirus Vaccine (RV5) Administered on an Early Alternative Dosing Schedule with Those of RV5 Administered on the Recommended Standard Schedule.” J Pediatric Infect Dis Soc 7, no. 1 (February 19, 2018): 82–85. https://doi.org/10.1093/jpids/pix005.
Saleh E, Eichner B, Clark DW, Gagliano ME, Troutman JM, Harrington L, et al. Open-Label Pilot Study to Compare the Safety and Immunogenicity of Pentavalent Rotavirus Vaccine (RV5) Administered on an Early Alternative Dosing Schedule with Those of RV5 Administered on the Recommended Standard Schedule. J Pediatric Infect Dis Soc. 2018 Feb 19;7(1):82–5.
Saleh, Ezzeldin, et al. “Open-Label Pilot Study to Compare the Safety and Immunogenicity of Pentavalent Rotavirus Vaccine (RV5) Administered on an Early Alternative Dosing Schedule with Those of RV5 Administered on the Recommended Standard Schedule.” J Pediatric Infect Dis Soc, vol. 7, no. 1, Feb. 2018, pp. 82–85. Pubmed, doi:10.1093/jpids/pix005.
Saleh E, Eichner B, Clark DW, Gagliano ME, Troutman JM, Harrington L, McNeal M, Clements D. Open-Label Pilot Study to Compare the Safety and Immunogenicity of Pentavalent Rotavirus Vaccine (RV5) Administered on an Early Alternative Dosing Schedule with Those of RV5 Administered on the Recommended Standard Schedule. J Pediatric Infect Dis Soc. 2018 Feb 19;7(1):82–85.
Published In
J Pediatric Infect Dis Soc
DOI
EISSN
2048-7207
Publication Date
February 19, 2018
Volume
7
Issue
1
Start / End Page
82 / 85
Location
England
Related Subject Headings
- Vaccines, Attenuated
- Rotavirus Vaccines
- Rotavirus Infections
- Rotavirus
- Pilot Projects
- Male
- Infant, Newborn
- Infant
- Immunization Schedule
- Humans